HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 1, 2001, Pages 46-48

  Macias J ^a   Pineda, J A ^a   Leal, M ^b   Abad, M A ^b   Delgado, J ^b   Rosa, R ^b   Rubio, A ^b   Sanchez Quijano A ^b   Lissen, E ^b  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; INFLUENZA VACCINATION; MALE; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

EID: 0035097114     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960000421     Document Type: Article

References (15)

1. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
2. Activation of virus replication after vaccination of HIV-1-infected individuals
3. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients
4. Efficacy of influenza vaccination in HIV-infected persons: A randomized, double-blind, placebo-controlled trial
5. The effect of influenza vaccination on human immunodeficiency virus type 1 load: A randomized double-blind, placebo-controlled study
6. Effects of influenza vaccination in HIV-infected adults: A double-blind, placebo-controlled trial
7. Vaccination and HIV-1 replication during highly active antiretroviral therapy
8. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
9. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
10. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: Case series
11. Short-term variability of plasma viremia among clinically stable HIV-infected individuals
12. Soluble tumor necrosis factor-α receptor type II (sTNF-αRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients
13. Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy
14. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection
15. Editorial response: Influenza, influenza virus vaccine, and human immunodeficiency virus infection